Specialties
TagsRheumatology 
SPEVIGO®

SPEVIGO ® (spesolimab) PFIZER HK Reg. No. HK-68915 (03 Dec, 2025) Composition: 2 For subcutaneous use: Injection: 150 mg/mL in a single-dose prefilled syringe Indication: 2 SPEVIGO ® is an interleukin-36 receptor antagonist indicated for the...

Feb 11, 2026
Cibinqo

Cibinqo (abrocitinib) Pfizer Composition: Each film-coated tablet contains 50mg or 100 mg or 200 mg of abrocitinib. Indications: Cibinqo is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with refractory, moderate-to-severe ...

Dec 18, 2023
Popular Story
The Earlier The Better: The New Frontiers of Lipid Research for Cardiovascular Disease Prevention
  • Dr. Feng Xue
  • Feb 11, 2026
Rare Genomic Targets in NSCLC: 2025 Breakthroughs in Precision Therapy and Future Directions
  • Dr. Feng Xue
  • Dec 19, 2025
Rheumatology in 2025: Breakthroughs, Technologies, and the Future of Care
  • Dr. Feng Xue
  • Oct 24, 2025
Breaking the Pathologic Combo of CVD and T2DM – Now and Then
  • Dr. Roy Lau
  • Aug 14, 2025
No More Itch – Uncovering Urticaria and Its Clinical Management
  • Dr. Roy Lau
  • Jun 13, 2025
What Should We Know About Anxiety Disorder?
  • Dr. Roy Lau
  • Apr 11, 2025
Specialties
More Contents
©2026 V-Pulse. All rights reserved.